Regentis Biomaterials Ltd. (RGNT) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Regentis Biomaterials Ltd. (RGNT) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $7.7M, listed on AMEX, employing roughly 10 people, carrying a beta of 1.42 to the broader market. Regentis Biomaterials Ltd. Led by Ehud Geller, public since 2025-09-11.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for RGNT as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.